Pages that link to "Q33329325"
Jump to navigation
Jump to search
The following pages link to Efficacy of interferon treatment for patients with chronic hepatitis C: comparison of response in cirrhotics, fibrotics, or nonfibrotics (Q33329325):
Displaying 20 items.
- Treatment of hepatitis C related thrombocytopenia with interferon alpha (Q33340288) (← links)
- Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response (Q33597579) (← links)
- Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens (Q33703634) (← links)
- Treatment of chronic hepatitis C virus infection (Q34072137) (← links)
- An emerging role for interferon in haemophiliacs with chronic hepatitis C? (Q34117203) (← links)
- Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection (Q34129547) (← links)
- Low-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of hepatocellular carcinoma (Q34225588) (← links)
- Interferon alfacon-1: a review of its pharmacology and therapeutic efficacy in the treatment of chronic hepatitis C. (Q34385411) (← links)
- Hepatocellular carcinoma--cause, treatment and metastasis (Q34512068) (← links)
- Acute pancreatitis associated with interferon and ribavirin therapy in patients with chronic hepatitis C. (Q35862482) (← links)
- Therapy of hepatitis C in patients with HIV infection (Q36162359) (← links)
- Review of consensus interferon in the treatment of chronic hepatitis C. (Q37586950) (← links)
- Immunopathogenesis of hepatitis C virus infection and hepatic fibrosis: New insights into antifibrotic therapy in chronic hepatitis C. (Q40211269) (← links)
- Histologic outcomes in hepatitis C-infected patients with varying degrees of virologic response to interferon-based treatments (Q42958282) (← links)
- Alpha-interferon improves liver fibrosis in chronic hepatitis C: clinical significance of the serum N-terminal propeptide of procollagen type III. (Q43709293) (← links)
- Managing patients with hepatitis-B-related or hepatitis-C-related decompensated cirrhosis (Q44074214) (← links)
- Role of interferons in the treatment of hepatitis B and hepatitis C virus infections (Q44248571) (← links)
- Chronic hepatitis C in patients coinfected by human immunodeficiency virus (Q50584513) (← links)
- Severe neutropenia and post-hepatitis C cirrhosis treatment: is interferon dose adaptation at once necessary? (Q74112729) (← links)
- Hepatocellular carcinoma (Q93930900) (← links)